BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30947911)

  • 1. Cardiac Phenotypes, Genetics, and Risks in Familial Noncompaction Cardiomyopathy.
    van Waning JI; Caliskan K; Michels M; Schinkel AFL; Hirsch A; Dalinghaus M; Hoedemaekers YM; Wessels MW; IJpma AS; Hofstra RMW; van Slegtenhorst MA; Majoor-Krakauer D
    J Am Coll Cardiol; 2019 Apr; 73(13):1601-1611. PubMed ID: 30947911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study.
    Jansen M; de Brouwer R; Hassanzada F; Schoemaker AE; Schmidt AF; Kooijman-Reumerman MD; Bracun V; Slieker MG; Dooijes D; Vermeer AMC; Wilde AAM; Amin AS; Lekanne Deprez RH; Herkert JC; Christiaans I; de Boer RA; Jongbloed JDH; van Tintelen JP; Asselbergs FW; Baas AF
    JACC Heart Fail; 2024 Jan; 12(1):134-147. PubMed ID: 37565978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Review of Genotype-Phenotype Correlations in Noncompaction Cardiomyopathy.
    van Waning JI; Moesker J; Heijsman D; Boersma E; Majoor-Krakauer D
    J Am Heart Assoc; 2019 Dec; 8(23):e012993. PubMed ID: 31771441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy.
    van Waning JI; Caliskan K; Hoedemaekers YM; van Spaendonck-Zwarts KY; Baas AF; Boekholdt SM; van Melle JP; Teske AJ; Asselbergs FW; Backx APCM; du Marchie Sarvaas GJ; Dalinghaus M; Breur JMPJ; Linschoten MPM; Verlooij LA; Kardys I; Dooijes D; Lekanne Deprez RH; IJpma AS; van den Berg MP; Hofstra RMW; van Slegtenhorst MA; Jongbloed JDH; Majoor-Krakauer D
    J Am Coll Cardiol; 2018 Feb; 71(7):711-722. PubMed ID: 29447731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies.
    Hoedemaekers YM; Caliskan K; Majoor-Krakauer D; van de Laar I; Michels M; Witsenburg M; ten Cate FJ; Simoons ML; Dooijes D
    Eur Heart J; 2007 Nov; 28(22):2732-7. PubMed ID: 17947214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
    Viswanathan SK; Sanders HK; McNamara JW; Jagadeesan A; Jahangir A; Tajik AJ; Sadayappan S
    PLoS One; 2017; 12(11):e0187948. PubMed ID: 29121657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biallelic mutation in MYH7 and MYBPC3 leads to severe cardiomyopathy with left ventricular noncompaction phenotype.
    Kolokotronis K; Kühnisch J; Klopocki E; Dartsch J; Rost S; Huculak C; Mearini G; Störk S; Carrier L; Klaassen S; Gerull B
    Hum Mutat; 2019 Aug; 40(8):1101-1114. PubMed ID: 30924982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.
    Velicki L; Jakovljevic DG; Preveden A; Golubovic M; Bjelobrk M; Ilic A; Stojsic S; Barlocco F; Tafelmeier M; Okwose N; Tesic M; Brennan P; Popovic D; Ristic A; MacGowan GA; Filipovic N; Maier LS; Olivotto I
    BMC Cardiovasc Disord; 2020 Dec; 20(1):516. PubMed ID: 33297970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.
    Ntusi NA; Shaboodien G; Badri M; Gumedze F; Mayosi BM
    Cardiovasc J Afr; 2016; 27(3):152-158. PubMed ID: 27841901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
    Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
    Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling.
    Tobita T; Nomura S; Fujita T; Morita H; Asano Y; Onoue K; Ito M; Imai Y; Suzuki A; Ko T; Satoh M; Fujita K; Naito AT; Furutani Y; Toko H; Harada M; Amiya E; Hatano M; Takimoto E; Shiga T; Nakanishi T; Sakata Y; Ono M; Saito Y; Takashima S; Hagiwara N; Aburatani H; Komuro I
    Sci Rep; 2018 Jan; 8(1):1998. PubMed ID: 29386531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.
    Weissler-Snir A; Hindieh W; Gruner C; Fourey D; Appelbaum E; Rowin E; Care M; Lesser JR; Haas TS; Udelson JE; Manning WJ; Olivotto I; Tomberli B; Maron BJ; Maron MS; Crean AM; Rakowski H; Chan RH
    Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28193612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR; Chu CT; Charng MJ
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Long-Term Outcome of Hypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding Protein C) Founder Mutation.
    van Velzen HG; Schinkel AFL; Oldenburg RA; van Slegtenhorst MA; Frohn-Mulder IME; van der Velden J; Michels M
    Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28794111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of inherited cardiomyopathy using next generation semiconductor sequencing technologies.
    Lu C; Wu W; Liu F; Yang K; Li J; Liu Y; Wang R; Si N; Gao P; Liu Y; Zhang S; Zhang X
    J Transl Med; 2018 Aug; 16(1):241. PubMed ID: 30165862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
    Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
    Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
    Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
    Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in sarcomere protein genes in left ventricular noncompaction.
    Klaassen S; Probst S; Oechslin E; Gerull B; Krings G; Schuler P; Greutmann M; Hürlimann D; Yegitbasi M; Pons L; Gramlich M; Drenckhahn JD; Heuser A; Berger F; Jenni R; Thierfelder L
    Circulation; 2008 Jun; 117(22):2893-901. PubMed ID: 18506004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.